| Direct Competitor Comparison | |
|---|
| XOMA | PVT1 | NVS | REGN | Industry |
|---|
| Market Cap: | 339.03M | N/A | 182.72B | 24.25B | 71.76B |
|---|
| Employees: | 167 | N/A | 129,000 | 1,996 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | -0.04 | N/A | 0.02 | 0.90 | 0.27 |
|---|
| Revenue (ttm):
| 33.37M | N/A | 57.80B | 1.59B | 13.93B |
|---|
| Gross Margin (ttm): | -0.07 | N/A | 0.68 | 0.52 | 0.72 |
|---|
| EBITDA (ttm): | -48.63M | N/A | 17.15B | 626.49M | 1.51B |
|---|
| Operating Margin (ttm):
| -1.57 | N/A | 0.22 | 0.37 | 0.13 |
|---|
| Net Income (ttm): | -65.53M | N/A | 9.66B | 837.49M | N/A |
|---|
| EPS (ttm): | -0.88 | N/A | 3.94 | 7.48 | 0.61 |
|---|
| P/E (ttm): | N/A | N/A | 18.87 | 33.47 | 18.43 |
|---|
| PEG (5 yr expected): | -0.26 | N/A | 2.73 | 2.63 | 1.51 |
|---|
| P/S (ttm): | 10.26 | N/A | 3.14 | 15.56 | 3.64 |
|---|
|
| Pvt1 = MedImmune, L.L.C. (privately held) | | NVS = Novartis AG | | REGN = Regeneron Pharmaceuticals, Inc. | | Industry = Biotechnology | |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 105.91 | 0.00 | 79.43B | 17.93 |
|---|
| Genentech, Inc. | "Private" |
|---|
| Biogen Idec Inc. | BIIB | 235.24 | 0.01 | 55.84B | 37.33 |
|---|
| Genzyme Corporation | "Private" |
|---|
| Merck Serono S.A. | "Private" |
|---|
| Gilead Sciences Inc. | GILD | 55.81 | 0.01 | 85.13B | 31.25 |
|---|
| MedImmune, L.L.C. | "Private" |
|---|
| Life Technologies Corporation | LIFE | 74.04 | 0.00 | 12.74B | 31.35 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 39.34 | -0.00 | 33.52B | 19.64 |
|---|
| Sandoz International GmbH | "Private" |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 127.23 | -0.01 | 16.25B | N/A |
|---|
| Ranbaxy Laboratories Limited | "Private" |
|---|
| Mylan, Inc. | MYL | 31.17 | -0.02 | 11.88B | 20.82 |
|---|
| Pfizer Inc. | PFE | 29.04 | -0.00 | 205.99B | 13.90 |
|---|
| Johnson & Johnson | JNJ | 86.82 | -0.00 | 243.87B | 23.58 |
|---|
| GlaxoSmithKline plc | GSK | 52.97 | 0.00 | 128.29B | 19.36 |
|---|
| Sanofi | SNY | 54.86 | 0.01 | 145.20B | 27.04 |
|---|
| Novartis AG | NVS | 74.36 | 0.01 | 182.72B | 18.87 |
|---|
| Roche Holding AG | RHHBY | 65.96 | 0.01 | 223.86B | 22.07 |
|---|
| AstraZeneca PLC | AZN | 52.17 | 0.00 | 65.21B | 11.54 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.76 | 0.01 | 58.86B | 11.51 |
|---|
| Bristol-Myers Squibb Company | BMY | 47.40 | 0.01 | 77.86B | 53.68 |
|---|
|
| News on Direct Competitors | |
|---|
No Direct Competitor ComparisionCurrency in USD. | |
|
0.04(0.97%) 25 May 1:30AM|After Hours
:
4.09